<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:0 0 3 0 0 0 0 0 0 0;}
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-US;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:24.0pt;
font-family:"Calibri",sans-serif;
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:"Calibri",sans-serif;
mso-fareast-language:EN-ZA;
font-weight:bold;}
p.elementor-icon-list-item, li.elementor-icon-list-item, div.elementor-icon-list-item
{mso-style-name:elementor-icon-list-item;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.elementor-icon-list-text
{mso-style-name:elementor-icon-list-text;}
span.EmailStyle24
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1642274641;
mso-list-template-ids:961314854;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:1723821319;
mso-list-template-ids:-213582768;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
-->@-ms-viewport {
width: device-width;
}
</style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<meta name="viewport" content="width=device-width, initial-scale=1">
</head>
<body lang="EN-ZA" link="#0563C1" vlink="#954F72" style="word-wrap:break-word"><table width="100%" border="0" cellpadding="0" cellspacing="0">
<tbody><tr><td style="max-width: 100%; height: auto;"><a href="https://rs.amdec.co.za/rs/13mZY.Nh"><img src="cid:image-1726-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td></tr></tbody></table><table border="0" cellpadding="0" cellspacing="0">
<tbody><tr><td style="max-width: 100%; height: auto;" valign="top"><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td style="max-width: 100%; height: auto;"><br>
<div class="WordSection1">
<div>
<div style="border:none;border-top:solid #FFFFFF 1.0pt;padding:3.0pt 0cm 0cm 0cm">
<p class="MsoNormal"><span lang="EN-US" style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
</div>
</div>
<p class="MsoNormal"><span style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" style="padding:0cm 0cm 0cm 0cm;max-width:100%">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%">
<tbody>
<tr>
<td style="padding:0cm 0cm 0cm 0cm;max-width:100%">
<p class="MsoNormal"><span style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica">Dear Residents,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica">After the latest report of a new Covid-19 variant, Elize Porter our MD of Health has shared the following update from 11 January and will keep us updated with any new information.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica">We are awaiting correspondence from the Department of Health but can advise that it is advisable to get a booster vaccine.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-family:Helvetica">This remains a personal choice and until otherwise indicated Evergreen Health will not be providing additional booster vaccinations.
<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
<h1 style="margin:0cm;background:white;vertical-align:baseline"><span style="font-size:12.0pt;font-family:Helvetica;color:#006F45;text-transform:uppercase">COVID-19 UPDATE: XBB.1.5 VARIANT<o:p></o:p></span></h1>
<ul style="margin-top:0cm;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-style:inherit;font-weight:inherit;display:flex;flex-wrap: wrap" type="disc">
<li class="elementor-icon-list-item" style="color:#3C402F;margin-top:0cm;margin-bottom:0cm;mso-list:l1 level1 lfo3;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-size:inherit;font-style:inherit;font-weight:var( --e-global-typography-text-font-weight );display:flex;-webkit-box-align: center;align-items: center;word-break:break-word">
<span style="font-size:12.0pt;font-family:Helvetica"><a href="https://www.nicd.ac.za/2023/01/11/"><span class="elementor-icon-list-text"><span style="color:#006F45;border:none windowtext 1.0pt;padding:0cm;text-decoration:none">11
January , 2023</span></span></a><o:p></o:p></span></li></ul>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:15.0pt;margin-left:0cm;text-align:justify;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-style:inherit;font-weight:inherit">
<span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D">The Omicron variant of concern has given rise to many new sublineages, including the BA.1 and BA.2 that were predominant in South Africa from November 2021 through March 2022. BA.4 and BA.5
became predominant in April 2022 and remained the predominant circulating sublineages throughout 2022. As of 9 January 2023, more than 650 sublineages of Omicron have been identified, of which more than 200 have been detected in South Africa. In September
2022, a new sublineage XBB was identified in the United States of America (USA) and Singapore. XBB is a recombinant of two BA.2 sublineages which means it contains the genetic material of both parent sublineages.<o:p></o:p></span></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:15.0pt;margin-left:0cm;text-align:justify;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-style:inherit;font-weight:inherit">
<span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D">The XBB sublineage has been shown to have increased immune evasion compared to previous sublineages. Since its identification, the XBB sublineage has given rise to several more sublineages,
including XBB.1, XBB.2, and XBB.3, that have been circulating in South Africa since October 2022. The XBB.1.5 sublineage was first detected in October 2022 in the USA and has since been detected in several other countries, with the first detection in South
Africa from a sample collected late in December 2022. With the growing distribution of XBB.1.5, it was not unexpected that it would be detected in South Africa. XBB.1.5 has been shown to have a growth advantage in the USA compared to previous variants, which
means it may outcompete other variants to become the dominant circulating variant in some settings. This sublineage is now being monitored as a “subvariant of concern”. The growth advantage is thought to be due to a substitution (F486P) in the spike protein
that increases the binding of the virus to the human ACE2 receptor and therefore increases the transmissibility of the virus.<o:p></o:p></span></p>
<p style="mso-margin-top-alt:0cm;margin-right:0cm;margin-bottom:15.0pt;margin-left:0cm;text-align:justify;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-style:inherit;font-weight:inherit">
<span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D">Thus far, it is not known if the severity of infection will be different to other Omicron sublineages. The World Health Organization (WHO) Technical Advisory Group on Virus Evolution is currently
conducting an ongoing risk assessment on XBB.1.5.<o:p></o:p></span></p>
<p style="margin:0cm;text-align:justify;background:white;vertical-align:baseline;box-sizing: border-box;outline: 0px;font-variant:inherit;font-stretch: inherit;line-height:inherit;font-style:inherit;font-weight:inherit">
<span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D">Due to the widespread circulation of other Omicron sublineages, and the overall high population immunity in South Africa, the introduction of XBB.1.5 in South Africa may not necessarily result
in a large wave of infections. Ongoing surveillance to track variants will continue to track the growth of XBB.1.5 in South Africa and information is published weekly on the</span><span style="font-size:12.0pt;color:#2D2D2D"> </span><span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D"><a href="https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/sars-cov-2-genomic-surveillance-update/"><span style="color:#2D2D2D;border:none windowtext 1.0pt;padding:0cm">NICD
website</span></a>. All private and public laboratories are requested to send positive SARS-CoV-2 specimens for genomic sequencing.</span><span style="font-size:12.0pt;color:#2D2D2D"> </span><strong><span style="font-size:12.0pt;font-family:Helvetica;color:#99CC00;border:none windowtext 1.0pt;padding:0cm">Currently,
no changes to the public health response are required, and individuals are encouraged to receive SARS-CoV-2 vaccination and boosters, as recommended by the National Department of Health, because vaccination has been shown to reduce the risk of hospitalisation
and death.</span></strong><span style="font-size:12.0pt;font-family:Helvetica;color:#2D2D2D"><o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-family:Helvetica"><o:p> </o:p></span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td style="padding:0cm 0cm 0cm 0cm;max-width:100%">
<p class="MsoNormal"><span style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span style="display:none;mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="100%" style="width:100.0%" id="rs-bottom-banner">
<tbody>
<tr>
<td style="padding:0cm 0cm 0cm 0cm;max-width:100%"></td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="display:none;mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="mso-fareast-language:EN-ZA"><o:p> </o:p></span></p>
</div>
</td></tr></tbody></table></td></tr><tr><td style="max-width: 100%; height: auto;"><br><table style="max-width: 650" border="0" cellpadding="0" cellspacing="0">
<tbody><tr><td style="max-width: 100%; height: auto;" colspan="2"><p style="margin: 0;"><font face="helvetica" size="3" style="color: #a39061;">Wilma Swart</font> <font face="helvetica" size="2">Village Manager</font></p></td><td style="max-width: 100%; height: auto;"> </td></tr><tr><td style="max-width: 100%; height: auto;"> </td><td style="max-width: 100%; height: auto;"> </td><td style="max-width: 100%; height: auto;" rowspan="5" align="right"><img src="cid:image-639-41584@rs.amdec.co.za" class="rocketseed-strip" usemap="#imgmap20161031122145" border="0" style="max-width: 100%; height: auto;"><map id="imgmap20161031122145" name="imgmap20161031122145">
<area shape="rect" alt="" coords="2,2,134,62" href="https://rs.amdec.co.za/rs/13S993.Z" target=""></map></td></tr><tr><td style="max-width: 100%; height: auto;" nowrap="nowrap"><p style="margin: 0;"><font face="helvetica" size="2"><b>Tel:</b> +27 87 809 3366</font></p></td><td style="max-width: 100%; height: auto;"><p style="margin: 0;"><font face="helvetica" size="2"><b>Fax:</b> +27 21 702 3201</font></p></td></tr><tr><td style="max-width: 100%; height: auto;"><p style="margin: 0;"><font face="helvetica" size="2"><b>Cell:</b> </font><font face="arial,helvetica,sans-serif" size="2">+27 83 280 0108</font></p></td><td style="max-width: 100%; height: auto;"><p style="margin: 0;"><font face="helvetica" size="2"><b>Email:</b> <a style="text-decoration: none; color: #000;" href="mailto:wilmas@evergreenlifestyle.co.za">wilmas@evergreenlifestyle.co.za</a></font></p></td></tr><tr><td style="max-width: 100%; height: auto;" colspan="2"><p style="margin: 0;"><font face="helvetica" size="2"><b>Postal:</b> Private Bag X5, Dainfern, Sandton, 2055</font></p></td></tr><tr><td style="max-width: 100%; height: auto;" colspan="2"><p style="margin: 0;"><font face="helvetica" size="2"><b>Website:</b> <a style="text-decoration: none; color: #000;" href="www.evergreenlifestyle.co.za">www.evergreenlifestyle.co.za</a></font></p></td></tr><tr><td style="max-width: 100%; height: auto;"> </td><td style="max-width: 100%; height: auto;"> </td><td style="max-width: 100%; height: auto;"> </td></tr><tr><td nowrap="nowrap" colspan="1">
<table>
<tbody><tr>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13c7sCzo"><img src="cid:image-848-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13rHORAF"><img src="cid:image-1382-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13Hnfdko"><img src="cid:image-850-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13fBEItU"><img src="cid:image-851-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13l0_VQ5"><img src="cid:image-852-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
</tr></tbody></table>
</td> <td style="max-width: 100%; height: auto;"> </td><td style="max-width: 100%; height: auto;"> </td></tr><tr><td height="1" style="max-width: 100%; height: 1;" bgcolor="#000000" colspan="3"></td></tr><tr><td nowrap="nowrap" colspan="3">
<table>
<tbody><tr>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13jxs_sw"><img src="cid:image-883-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13NHF8Bm"><img src="cid:image-884-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13xZ9bET"><img src="cid:image-885-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td>
<td style="max-width: 100%; height: auto;" align="left" valign="top"><a href="https://rs.amdec.co.za/rs/13PSN7Br"><img src="cid:image-886-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></a></td></tr><tr>
<td style="max-width: 100%; height: auto;" align="left" valign="top" colspan="4"><img src="cid:image-943-41584@rs.amdec.co.za" class="rocketseed-strip" border="0" beacon_priority="0" style="max-width: 100%; height: auto;"></td>
</tr></tbody></table>
</td>
</tr><tr><td height="1" style="max-width: 100%; height: 1;" bgcolor="#000000" colspan="3"></td></tr><tr><td style="max-width: 100%; height: auto;"></td></tr><tr><td style="max-width: 100%; height: auto;"></td></tr></tbody></table></td></tr></tbody></table><table id="rs-bottom-banner" width="100%" border="0" cellpadding="0" cellspacing="0">
<tbody><tr><td style="max-width: 100%; height: auto;"></td></tr></tbody></table><table id="rs-disclaimer" width="100%" border="0" cellpadding="0" cellspacing="0">
<tbody><tr><td style="max-width: 100%; height: auto;"><br><table border="0" cellpadding="0" cellspacing="0" width="650">
<tbody><tr><td style="max-width: 100%; height: auto;"><p style="margin: 0; color: #888888;" align="full"><font face="trebuchet ms,geneva" size="1"><strong>Authority to Contract </strong><br> No agreement binding the company will come into effect unless reduced to writing and signed by a duly authorised director of the company. <br> <br> <strong>Confidentiality Notice </strong><br> This is a legally privileged and confidential communication intended only for the addressee. If you are not the intended recipient or you have received this communication in error, you are hereby strictly prohibited from using, disseminating, distributing, modifying, varying or copying this e-mail or any of the attachments or parts thereof, and you are kindly requested to notify us and delete the erroneous communication. Neither Amdec, its directors, officers, employees, agents, independent contractors, representatives, subsidiaries, affiliates, associated-, controlling- and/or holding companies and insurers, past and present, shall be liable for any direct, indirect, special, consequential or other damage or loss of any kind whatsoever and howsoever suffered or incurred, arising from this email and/or from the accessing of any attachments, including but not necessarily limited to loss or damage/s caused by any type of malicious software.</font></p></td></tr></tbody></table></td></tr></tbody></table></body>
</html>